Find a TenderAwarded
Published 4 May 2023, 14:09 BST

Official UK procurement notice

Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)

Official notice

Authority: CORNWALL PARTNERSHIP NHS FOUNDATION TRUST (Central government)

Framework agreementGoodsOpen procedure
Framework ceiling (notional)£80,000,000framework ceiling, not attributable revenue
Submissions closed 13 Jul 2023awarded 18 Jun 2024

What is being bought

Published requirement description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices.

This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

CPV: Infusion solutions · Injectable solutions · Intravenous fluids · Pharmaceutical products · Toxins · Various medicinal products

How this framework works

From the published notice
Places
up to 10 suppliers · 5 bids received (0.5 per place) · 5 appointed

The lotProcurement structure

single lot · value published
Lot #1Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide,…AwardedPublished value£80,000,000

Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Blinatumomab, Brentuximab, Bupivacaine, Carfilzomib, Cetuximab, Daratumumab, Eribulin Mesylate, Etoposide, Fludarabine Fluorouracil elastomeric devices, Ifosfamide, Infliximab, Ipilimumab, Methotrexate, Natalizumab, Obinutuzumab, Paclitaxel Albumin, Panitumumab, Pemetrexed, Pertuzumab, Rituximab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Vinorelbine.

Delivery: UK, South West · Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
Variant bids: not allowed

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Quality: 90%Social value: 10%
Published sub-criteria (2)
  • QA Processes & Service: 90%
  • Social Value: 10%
Published award criteria (3)
  • QA Processes & Service: 90%
  • Social Value: 10%
  • Price: 0%
What this means for your bid
  • “Aseptically Manipulated or Terminally Sterile Medicinal Products…” is a framework: the contest is a place on its panel, up to 10 suppliers, not a single contract.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
No (one-off requirement)
First published
4 May 2023, 14:09 BST
Last source update
20 Aug 2024, 10:04 BST
Award evaluation window
6 Jun 2023 – …
Authority reference
T22/0446 Lot 5 Framework
FTS notice number
2024/S 000-026412
Classification (CPV)
Infusion solutionsInjectable solutionsIntravenous fluidsPharmaceutical productsToxinsVarious medicinal products
Delivery area
UKSouth West (UKK)
Official registry OCID
ocds-h6vhtk-03c658 Find a Tender

Publisher note: The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.

How it was run

Official notice
Run through: EU-Supply (CTM) · Who buys & how to bid on EU-Supply
Public notice page · account needed to bidLanguage: EN
Access & registration note: Free · 5–10 minutes
Appointment period ends
13 Jul 2023, 12:00 BST
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bid validity
240 days from the deadline
Bids opened
6 Jun 2023, 09:00 BST
Detailed submission instructions & authority contactsFrom official release

Timeline

6 Jun 2023 → 20 Aug 2024 · 3 dates
  1. Bids opened
    6 Jun 2023, 09:00 BST
  2. Admission / appointment period endsperiod end, not a bid countdown
    13 Jul 2023, 12:00 BST
  3. Notice published
    20 Aug 2024, 10:04 BST

Notice history

3 events · 4 releases on Find a Tender · since 18 May 2023
  1. Deadline moved to 16 Jun 2023, 12:00 BST
    18 May 2023, 12:09 BST
    +11 days · was 5 Jun 2023, 14:00 BST
  2. Deadline moved to 13 Jul 2023, 12:00 BST
    8 Jun 2023, 15:24 BST
    +27 days · was 16 Jun 2023, 12:00 BST
  3. Status changed to complete
    20 Aug 2024, 10:04 BST
Published amendments (2 · 2 deadline changes)
WhenWhatBeforeAfterShift
—DeadlineTime limit for receipt of tenders · IV.2.25 Jun 202316 Jun 2023+11 d
—Bid openingConditions for opening of tenders · IV.2.76 Jun 202316 Jun 2023+10 d
—DeadlineTime limit for receipt of tenders · IV.2.216 Jun 202313 Jul 2023+27 d
—Bid openingConditions for opening of tenders · IV.2.76 Jun 202313 Jul 2023+37 d
—TextDuration of Contract · II.2.748 months36 months
—TextDescription of options · II.2.11Options: NoOption to extend for any period up to 12 months.

2 amendments published without a description.

Routine re-releases (4)
  • 2023-05: 1 release · 4 May 2023

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 5admitted to the panel · see the list ↓
Bids received 5
Contracts signed 5latest 18 Jun 2024

5 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 3 of these contracts carry the same published figure, £20,000,000, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Contract 4 - Quantum Pharmaceutical Limited

    Signed
    18 Jun 2024
    Value
    ceiling above
    Status
    active
  • Contract 3 - Sciensus Pharma Services Ltd

    Signed
    30 May 2024
    Value
    £19,000,000
    Status
    active
  • Contract 2 - Qualasept Ltd t/a Bath ASU

    Signed
    28 May 2024
    Value
    ceiling above
    Status
    active
  • Contract 1 - Baxter Healthcare Ltd

    Signed
    24 May 2024
    Value
    ceiling above
    Status
    active
  • Contract 5 - Liverpool University Hospitals NHS Foundation Trust

    Signed
    11 Apr 2024
    Value
    £1,000,000
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
5bids · 5 electronic———

Contracting authority & participating public bodies

NHS South West - Acutes

Contracting authorityCentral GovernmentRegional or local authorityHealth 1234 Acute Trusts, Exeter, South West, South west regionContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Peninsula Purchasing & Supply AllianceMediation bodyReview bodyReview contact point Exeter

Framework contractors & participating bidders

5 commercial parties on the notice

Official documents & specifications (1)

Official links; attachments are not copied

Tender pack and attachments

  • Technical selection criteriatenderTechnical selection criteria